DOCSLIB.ORG

Apoptosis: Programmed Cell Death

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Apoptosis: Programmed Cell Death BASIC SCIENCE FOR SURGEONS Apoptosis: Programmed Cell Death Nai-Kang Kuan BS; Edward Passaro, Jr, MD urrently there is much interest and excitement in the understanding of how cells un- dergo the process of apoptosis or programmed cell death. Understanding how, why, and when cells are instructed to die may provide insight into the aging process, au- toimmune syndromes, degenerative diseases, and malignant transformation. This re- viewC focuses on the development of apoptosis and describes the process of programmed cell death, some of the factors that incite or prevent its occurrence, and finally some of the diseases in which it may play a role. The hope is that in the not too distant future we may be able to modify or thwart the apoptotic process for therapeutic benefit. The notion that cells are eliminated or ab- tact with that target cell. In experiments, the sorbed in an orderly manner is not new. death or survival of neurons could be modu- What is new is the recognition that this is lated by the loss of NGF, by antibodies, or an important physiologic process.1 More by the addition of exogenous NGF. During than 40 years ago embryologists noted that development and maturation, many types during morphogenesis cells and tissues ofneuronsarebeingproducedinexcess.This were being deleted in a predictable fash- seemingly extravagant waste of excessive ion. During human development as on- neurons has several survival advantages for togeny recapitulates phylogeny, there is the theorganism.Forexampleneuronsthathave loss of branchial arches, the tail, the cloaca, found their way to the wrong target cell do and webbing between fingers. Pediatric not survive. In turn, the large excess of neu- surgery is replete with examples where rons make it unlikely that any target cell will there has been failure of this process, with not make contact with the appropriate neu- double aortic arch, sacrococcygeal tera- ron. The result is that an excellent balance tomas, extrophy of the bladder, and syn- is achieved between the surviving neurons dactyly to name but a few. It is now rec- and target cells. ognized that apoptosis continues on after development, while the organism is un- APOPTOSIS VS NECROSIS dergoing growth and maturation. In fact the process is life long. Apoptosis stands in sharp contrast to Anexcellentexampleoftheimportance necrosis—a condition familiar to surgeons of programmed cell death during both de- (Figure). Necrosis is caused by an exter- velopment and maturation is provided by nal noxious stimulus and involves con- the vertebrate nervous system. Here again tiguous portions of tissue. The process is therewaslong-standingrecognitionthatdur- passive and pathologic in that injury is pro- ing development the death of neurons is a duced. The insult causes lysis or rupture regular feature, but only recently has the ex- of cell membranes and the leakage of cyto- tent of the neuronal death (50%) and its im- sol into the surroundings. Organelles such portance become understood.2 The seminal as mitochondria are easily injured whereas observations include the discovery of a nerve the nucleus, protected by a strong mem- growth factor (NGF) produced by the tar- brane, may remain intact. The escape of the get cell that is required for the sustenance cytosol releases kinins into the tissue that of the neuron responsible for making con- incite inflammation. Edema, capillary di- lation, and macrophage aggregation ensue. From the Department of Toxicology, University of Cincinnati, Cincinnati, Ohio The inflammatory response takes hours to (Mr Kuan); and the Department of Surgery, West Los Angeles Veterans Affairs days to both occur and subside and leaves Medical Center (Dr Passaro), Los Angeles, Calif. traces of its presence by scar formation. ARCH SURG/ VOL 133, JULY 1998 773 ©1998 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 Apoptosis (literally a “falling off” Necrosis Apoptosis as with leaves) occurs because of a preprogrammed process contained within the cell that can be either ac- tivated by the cell itself or by exter- nal stimuli. Specific genes have been Chromatin identified that regulate the process. It Chromatin is an active and physiologic process Segments that requires the cell to expend en- ergy in causing its own demise. Ini- tially, an individual cell becomes loose Nucleus or detached from its neighbors and Mitochondria Cytochrome morphologically shrinks. The cell Bcl-2 c membrane becomes contorted and White Blood Cell folded into blebs. Intracellular pro- teases (interleukin converting en- Necrosis Apoptosis zymes) activate enzymes that begin to 3 Process Pathological Physiologic cleave the cytoskeletal framework. Energy Passive Active The chromatin becomes condensed Stimulus External Internal near the nuclear membrane and is cut Host response Inflammation None into regular repeating lengths. The Cell membrane Ruptured Intact Blebs 36+9 blebs of the intact cell membrane, Mitochondria Loss Intact (Release Cytochrome c) Duration Days Hours many of which now contain con- Result Scar None/apoptotic bodies densed nuclear fragments (apop- totic bodies), pinch off as separate Differences between apoptosis and necrosis. packets. Although these packets may undergo phagocytosis by macro- For example, in both the developing mous cells on the surface. Similarly, phages, there is no inflammatory re- and mature intestine the survival of during menstruation the sloughed sponse. The process is relatively rapid, an individual cell can be dependent uterineliningquicklyundergoesapop- reaching completion in approxi- on contact with an extracellular ma- tosis as the cells are deprived of hor- mately 2 hours. Apoptotic bodies are trix, or a threshold level of a growth mones necessary for survival. Above the only visible remains. For these rea- or a stimulatory substance.5 The loss all, maintaining the appropriate cell sons the process and its magnitude of either can cause the activation of mass of an organ depends on a balance went undetected for a long time. the cell’s intrinsic destruction or sui- between production of new cells and cide mechanism. During the devel- the loss of old cells by programmed APOPTOSIS AND opment of the gut, the solid tube of cell death. HOMEOSTASIS cells develops a lumen by apoptosis of the centrally located cells because MECHANISM OF APOPTOSIS Activation of apoptosis is only partly of a loss of contact with the periph- understood and the object of much eral extracellular matrix. In the fully Two opposing mechanisms that investigation. The process may be ini- developed bowel, as enterocytes mi- maintain homeostatic control of tiated by agents such as bacterial tox- grate toward the tip of the villus they apoptosis are the Fas ligand8 and the ins, viral infections, and cytolytic T lose contact with the basement mem- protein expressed by the Bcl-2 gene.9 lymphocytes.4 This pathway can be brane and become apoptotic.6 Hence The Fas ligand promotes cell death thought of as serving a “housekeep- the bowel does not slough off viable by binding to Fas, a cell membrane ing function” to ensure that cells that cells into its lumen, but rather cells receptor, initiating a series of intra- have become injured, infected, al- that are dead. This is similar to the cellular events leading to apopto- tered or incompetent are removed in skin that sloughs off dead cells at its sis. Fas expression can be induced an expeditious and efficient man- surface. The death of cells that have by encountering an antigen, as oc- ner. For example, a lymphocyte in- lost contact with the extracellular ma- curs with T cells, or it may be ex- fected with the Epstein-Barr virus, a trix or with each other is termed pressed at some low level by the tis- virus with a potential to cause malig- anoias (“homelessness”). Similarly, sue itself. The Fas ligand can be nant transformation of the cell, would neurons that fail to receive sufficient induced and up-regulated by the be stimulated to undergo apoptosis NGF, for whatever reason, undergo presence of kinins such as interleu- and thereby lessen the risk to the or- apoptosis.7 kins. The complexing of Fas to the ganism. The virus or other noxious Programmed cell death is impor- Fas ligand, whether on the surface agents activate specific receptors and tant in many physiologic processes. of the same cell or with another cell, genes for apoptosis resulting in The most evident example is the skin. initiates the apoptotic process. prompt elimination of the affected Epidermal cells grow from the basal The Bcl-2 gene is an interesting lymphocytes. germinal layer and migrate to the sur- and important gene involved in hu- The other major pathway can be face. En route they undergo apopto- man malignancies such as B-cell lym- conceived as a homeostatic process. sis, resulting in flattened dead squa- phomas from which it derives its ARCH SURG/ VOL 133, JULY 1998 774 ©1998 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 name. It has been highly conserved them. The result is the loss of most these cancer therapies rely on induc- from primitive worms up to humans of the secreting thyroid. This is not ingapoptosisincellsthathavesuffered and, therefore, thought to be impor- the result of attacking monocytes DNA damage.18 Similarly tumors with tant. It is the best characterized gene and macrophages, but rather of ex- p53 deficiencies are much less respon- of a family of genes that may affect cessive activation of programmed sive to anticancer therapies. programmed cell death. Protein ex- cell death. This is an important pressed by Bcl-2 inhibits the apop- modification of our paradigm of totic process and is powerful enough some autoimmune diseases such as Corresponding author: Edward Pas- to block the process in the early Hashimoto thyroiditis. saro, Jr, MD, Department of Surgery, phases.10 Bcl-2 is intimately associ- However, other chronic auto- West Los Angeles Veterans Affairs ated with the outer mitochondrial immune diseases such as systemic lu- Medical Center, 11301 Wilshire Blvd, membrane.
Load more

Recommended publications
  • Restoring MLL Reactivates Latent Tumor Suppression-Mediated Vulnerability to Proteasome Inhibitors
    Oncogene (2020) 39:5888–5901 https://doi.org/10.1038/s41388-020-01408-7 ARTICLE Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors 1 1 2 1 3 1 4 2 Maolin Ge ● Dan Li ● Zhi Qiao ● Yan Sun ● Ting Kang ● Shouhai Zhu ● Shifen Wang ● Hua Xiao ● 1 5 4 1 Chunjun Zhao ● Shuhong Shen ● Zhenshu Xu ● Han Liu Received: 12 March 2020 / Revised: 16 July 2020 / Accepted: 23 July 2020 / Published online: 30 July 2020 © The Author(s) 2020. This article is published with open access Abstract MLL undergoes multiple distinct chromosomal translocations to yield aggressive leukemia with dismal outcomes. Besides their well-established role in leukemogenesis, MLL fusions also possess latent tumor-suppressive activity, which can be exploited as effective cancer treatment strategies using pharmacological means such as proteasome inhibitors (PIs). Here, using MLL-rearranged xenografts and MLL leukemic cells as models, we show that wild-type MLL is indispensable for the latent tumor-suppressive activity of MLL fusions. MLL dysfunction, shown as loss of the chromatin accumulation and subsequent degradation of MLL, compromises the latent tumor suppression of MLL-AF4 and is instrumental for the 1234567890();,: 1234567890();,: acquired PI resistance. Mechanistically, MLL dysfunction is caused by chronic PI treatment-induced epigenetic reprogramming through the H2Bub-ASH2L-MLL axis and can be specifically restored by histone deacetylase (HDAC) inhibitors, which induce histone acetylation and recruits MLL on chromatin to promote cell cycle gene expression. Our findings not only demonstrate the mechanism underlying the inevitable acquisition of PI resistance in MLL leukemic cells, but also illustrate that preventing the emergence of PI-resistant cells constitutes a novel rationale for combination therapy with PIs and HDAC inhibitors in MLL leukemias.
    [Show full text]
  • Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its
    Published OnlineFirst January 21, 2015; DOI: 10.1158/1078-0432.CCR-14-1950 Biology of Human Tumors Clinical Cancer Research Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis Longlong Cao1,2, Jiechao Zhou2, Junrong Zhang1,2, Sijin Wu3, Xintao Yang1,2, Xin Zhao2, Huifang Li2, Ming Luo1, Qian Yu1, Guangtan Lin1, Huizhong Lin1, Jianwei Xie1, Ping Li1, Xiaoqing Hu3, Chaohui Zheng1, Guojun Bu2, Yun-wu Zhang2,4, Huaxi Xu2,4,5, Yongliang Yang3, Changming Huang1, and Jie Zhang2,4 Abstract Purpose: As a cyclin-independent atypical CDK, the role of correlated with the severity of gastric cancer based on tumor CDK5 in regulating cell proliferation in gastric cancer remains and lymph node metastasis and patient 5-year fatality rate. unknown. Nuclear localization of CDK5 was found to be significantly Experimental Design: Expression of CDK5 in gastric tumor decreased in tumor tissues and gastric cancer cell lines, and paired adjacent noncancerous tissues from 437 patients was whereas exogenously expression of nucleus-targeted CDK5 measured by Western blotting, immunohistochemistry, and real- inhibited the proliferation and xenograft implantation of time PCR. The subcellular translocation of CDK5 was monitored gastric cancer cells. Treatment with the small molecule during gastric cancer cell proliferation. The role of nuclear CDK5 NS-0011, which increases CDK5 accumulation in the nucleus, in gastric cancer tumorigenic proliferation and ex vivo xenografts suppressed both cancer cell proliferation and xenograft was explored. Furthermore, by screening for compounds in the tumorigenesis. PubChem database that disrupt CDK5 association with its nu- Conclusions: Our results suggest that low CDK5 expression is clear export facilitator, we identified a small molecular (NS-0011) associated with poor overall survival in patients with gastric that inhibits gastric cancer cell growth.
    [Show full text]
  • Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons After DNA Damage
    The Journal of Neuroscience, July 15, 2001, 21(14):5017–5026 Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons after DNA Damage Erick J. Morris,1 Elizabeth Keramaris,2 Hardy J. Rideout,3 Ruth S. Slack,2 Nicholas J. Dyson,1 Leonidas Stefanis,3 and David S. Park2 1Massachusetts General Hospital Cancer Center, Laboratory of Molecular Oncology, Charlestown, Massachusetts 02129, 2Neuroscience Research Institute, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada, and 3Columbia University, New York, New York 10032 DNA damage has been implicated as one important initiator of ization, and DNA binding that result from DNA damage are not cell death in neuropathological conditions such as stroke. Ac- affected by the inhibition of CDK activity. Conversely, no de- cordingly, it is important to understand the signaling processes crease in retinoblastoma protein (pRb) phosphorylation was that control neuronal death induced by this stimulus. Previous observed in p53-deficient neurons that were treated with camp- evidence has shown that the death of embryonic cortical neu- tothecin. However, either p53 deficiency or the inhibition of rons treated with the DNA-damaging agent camptothecin is CDK activity alone inhibited Bax translocation, cytochrome c dependent on the tumor suppressor p53 and cyclin-dependent release, and caspase-3-like activation. Taken together, our re- kinase (CDK) activity and that the inhibition of either pathway sults indicate that p53 and CDK are activated independently alone leads to enhanced and prolonged survival. We presently and then act in concert to control Bax-mediated apoptosis. show that p53 and CDKs are activated independently on par- allel pathways.
    [Show full text]
  • Caspase-Dependent Activation of Cyclin-Dependent Kinases During Fas-Induced Apoptosis in Jurkat Cells
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 6785–6790, June 1998 Cell Biology Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells BIN-BING ZHOU,HONGLIN LI,JUNYING YUAN, AND MARC W. KIRSCHNER Department of Cell Biology, Harvard Medical School, Boston, MA 02115 Contributed by Marc W. Kirschner, April 7, 1998 ABSTRACT The activation of cyclin-dependent kinases To study the mechanism of cdc2 and cdk2 activation in (cdks) has been implicated in apoptosis induced by various apoptotic cells, we examined cyclin synthesis, cyclin degrada- stimuli. We find that the Fas-induced activation of cdc2 and tion, and posttranslational modifications of cdc2 and cdk2 cdk2 in Jurkat cells is not dependent on protein synthesis, during Fas-induced apoptosis in Jurkat cells. We find that Fas which is shut down very early during apoptosis before induction activates cdc2 and cdk2, despite a potential loss of caspase-3 activation. Instead, activation of these kinases these proteins caused by the very rapid drop in the capacity for seems to result from both a rapid cleavage of Wee1 (an protein synthesis. Activation of these kinases seems to result inhibitory kinase of cdc2 and cdk2) and inactivation of from the maintenance of cyclin levels by rapid inactivation of anaphase-promoting complex (the specific system for cyclin APC, through a caspase-dependent cleavage of one of its degradation), in which CDC27 homolog is cleaved during subunits, and tyrosine dephosphorylation of cdks caused by a apoptosis. Both Wee1 and CDC27 are shown to be substrates cleavage of the inhibitory kinase Wee1.
    [Show full text]
  • The Nature of Programmed Cell Death
    Biological Theory https://doi.org/10.1007/s13752-018-0311-0 ORIGINAL ARTICLE The Nature of Programmed Cell Death Pierre M. Durand1 · Grant Ramsey2 Received: 14 March 2018 / Accepted: 10 October 2018 © Konrad Lorenz Institute for Evolution and Cognition Research 2018 Abstract In multicellular organisms, cells are frequently programmed to die. This makes good sense: cells that fail to, or are no longer playing important roles are eliminated. From the cell’s perspective, this also makes sense, since somatic cells in multicel- lular organisms require the cooperation of clonal relatives. In unicellular organisms, however, programmed cell death (PCD) poses a difficult and unresolved evolutionary problem. The empirical evidence for PCD in diverse microbial taxa has spurred debates about what precisely PCD means in the case of unicellular organisms (how it should be defined). In this article, we survey the concepts of PCD in the literature and the selective pressures associated with its evolution. We show that defini- tions of PCD have been almost entirely mechanistic and fail to separate questions concerning what PCD fundamentally is from questions about the kinds of mechanisms that realize PCD. We conclude that an evolutionary definition is best able to distinguish PCD from closely related phenomena. Specifically, we define “true” PCD as an adaptation for death triggered by abiotic or biotic environmental stresses. True PCD is thus not only an evolutionary product but must also have been a target of selection. Apparent PCD resulting from pleiotropy, genetic drift, or trade-offs is not true PCD. We call this “ersatz PCD.” Keywords Adaptation · Aging · Apoptosis · Price equation · Programmed cell death · Selection · Unicellular organisms Introduction in animal ontogeny, was made explicit several decades later (Glücksmann 1951; Lockshin and Williams 1964).
    [Show full text]
  • Epithelial Cell Death Analysis of Cell Cycle by Flow Cytometry White Paper
    Epithelial Cell Death Analysis of Cell Cycle by Flow Cytometry White Paper Authors: Savithri Balasubramanian, John Tigges, Vasilis Toxavidis, Heidi Mariani. Affiliation: Beth Israel Deaconess Medical Center Harvard Stem Cell Institute a Beckman Coulter Life Sciences: Epithelial Cell Death Analysis of Cell Cycle by Flow Cytometry PRINCIPAL OF TECHNIQUE Background: Cell cycle, or cell-division cycle, is the series of events that takes place in a cell leading to its division and duplication (replication). In cells without a nucleus (prokaryotic), cell cycle occurs via a process termed binary fission. In cells with a nucleus (eukaryotes), cell cycle can be divided in two brief periods: interphase—during which the cell grows, accumulating nutrients needed for mitosis and duplicating its DNA—and the mitosis (M) phase, during which the cell splits itself into two distinct cells, often called «daughter cells». Cell-division cycle is a vital process by which a single-celled fertilized egg develops into a mature organism, as well as the process by which hair, skin, blood cells, and some internal organs are renewed. Cell cycle consists of four distinct phases: G1 phase, S phase (synthesis), G2 phase (collectively known as interphase) and M phase (mitosis). M phase is itself composed of two tightly coupled processes: mitosis, in which the cell’s chromosomes are divided between the two daughter cells, and cytokinesis, in which the cell’s cytoplasm divides in half forming distinct cells. Activation of each phase is dependent on the proper progression and completion of the previous one. Cells that have temporarily or reversibly stopped dividing are said to have entered a state of quiescence called G0 phase.
    [Show full text]
  • Transcriptional Regulation of the P16 Tumor Suppressor Gene
    ANTICANCER RESEARCH 35: 4397-4402 (2015) Review Transcriptional Regulation of the p16 Tumor Suppressor Gene YOJIRO KOTAKE, MADOKA NAEMURA, CHIHIRO MURASAKI, YASUTOSHI INOUE and HARUNA OKAMOTO Department of Biological and Environmental Chemistry, Faculty of Humanity-Oriented Science and Engineering, Kinki University, Fukuoka, Japan Abstract. The p16 tumor suppressor gene encodes a specifically bind to and inhibit the activity of cyclin-CDK specific inhibitor of cyclin-dependent kinase (CDK) 4 and 6 complexes, thus preventing G1-to-S progression (4, 5). and is found altered in a wide range of human cancers. p16 Among these CKIs, p16 plays a pivotal role in the regulation plays a pivotal role in tumor suppressor networks through of cellular senescence through inhibition of CDK4/6 activity inducing cellular senescence that acts as a barrier to (6, 7). Cellular senescence acts as a barrier to oncogenic cellular transformation by oncogenic signals. p16 protein is transformation induced by oncogenic signals, such as relatively stable and its expression is primary regulated by activating RAS mutations, and is achieved by accumulation transcriptional control. Polycomb group (PcG) proteins of p16 (Figure 1) (8-10). The loss of p16 function is, associate with the p16 locus in a long non-coding RNA, therefore, thought to lead to carcinogenesis. Indeed, many ANRIL-dependent manner, leading to repression of p16 studies have shown that the p16 gene is frequently mutated transcription. YB1, a transcription factor, also represses the or silenced in various human cancers (11-14). p16 transcription through direct association with its Although many studies have led to a deeper understanding promoter region.
    [Show full text]
  • P14arf Induces G2 Arrest and Apoptosis Independently of P53
    Oncogene (2003) 22, 1822–1835 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc ARF p14 induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice Be´ atrice Eymin, Camille Leduc, Jean-Luc Coll, Elisabeth Brambilla and Sylvie Gazzeri Groupe de Recherche sur le Cancer du Poumon, EA 2021, Equipe INSERM 9924, Institut Albert Bonniot, 38706 La Tronche Cedex, France Until recently, the ability of ARF (human p14ARF, murine kinases (Serrano et al., 1993). On the other hand, ARF p19ARF) tumour-suppressor protein, encoded by the protects against cellular transformation and immortali- INK4A/ARF locus, to inhibit cell growth in response to zation by activating the p53tumour suppressive protein various stimuli was related to its ability to stabilize p53 (Sherr, 1998). Expression of ARF is induced in response through the so-called ARF/MDM2/p53 pathway. How- to activated oncogenes such as Ras (Serrano et al., 1997; ever, recent data have demonstrated that ARF is not Palmero et al., 1998), c-myc (Zindy et al., 1998), E1A (de implicated in this unique p53-dependent pathway. By use Stanchina et al., 1998), Abl (Radfar et al., 1998; Cong of transient and stable expression, we show here that et al., 1999) and E2F-1 (Bates et al., 1998; Dimri et al., human p14ARF inhibits the growth of human tumoral cells 2000) as well as during replicative senescence (Sherr, lacking functional p53 by inducing a transient G2 arrest 1998). Since ARF-null mice are highly tumour prone ARF and subsequently apoptosis.
    [Show full text]
  • Snapshot: BCL-2 Proteins J
    SnapShot: BCL-2 Proteins J. Marie Hardwick and Richard J. Youle Johns Hopkins, Baltimore, MD 21205, USA and NIH/NINDS, Bethesda, MD 20892, USA 404 Cell 138, July 24, 2009 ©2009 Elsevier Inc. DOI 10.1016/j.cell.2009.07.003 See online version for legend and references. SnapShot: BCL-2 Proteins J. Marie Hardwick and Richard J. Youle Johns Hopkins, Baltimore, MD 21205, USA and NIH/NINDS, Bethesda, MD 20892, USA BCL-2 family proteins regulate apoptotic cell death. BCL-2 proteins localize to intracellular membranes such as endoplasmic reticulum and mitochondria, and some fam- ily members translocate from the cytoplasm to mitochondria following a cell death stimulus. The prototypical family member Bcl-2 was originally identified at chromo- some translocation breakpoints in human follicular lymphoma and was subsequently shown to promote tumorigenesis by inhibiting cell death rather than by promoting cell-cycle progression. BCL-2 family proteins have traditionally been classified according to their function and their BCL-2 homology (BH) motifs. The general categories include multidomain antiapoptotic proteins (BH1-BH4), multidomain proapoptotic proteins (BH1-BH3), and proapoptotic BH3-only proteins (see Table 1). In the traditional view, anti-death BCL-2 family members in healthy cells hold pro-death BCL-2 family members in check. Upon receiving a death stimulus, BH3-only proteins inactivate the protective BCL-2 proteins, forcing them to release their pro-death partners. These pro-death BCL-2 family proteins homo-oligomerize to create pores in the mitochondrial outer membrane, resulting in cytochrome c release into the cytoplasm, which leads to caspase activation and cell death.
    [Show full text]
  • Sonic Hedgehog a Neural Tube Anti-Apoptotic Factor 4013 Other Side of the Neural Plate, Remaining in Contact with Midline Cells, RESULTS Was Used As a Control
    Development 128, 4011-4020 (2001) 4011 Printed in Great Britain © The Company of Biologists Limited 2001 DEV2740 Anti-apoptotic role of Sonic hedgehog protein at the early stages of nervous system organogenesis Jean-Baptiste Charrier, Françoise Lapointe, Nicole M. Le Douarin and Marie-Aimée Teillet* Institut d’Embryologie Cellulaire et Moléculaire, CNRS FRE2160, 49bis Avenue de la Belle Gabrielle, 94736 Nogent-sur-Marne Cedex, France *Author for correspondence (e-mail: [email protected]) Accepted 19 July 2001 SUMMARY In vertebrates the neural tube, like most of the embryonic notochord or a floor plate fragment in its vicinity. The organs, shows discreet areas of programmed cell death at neural tube can also be recovered by transplanting it into several stages during development. In the chick embryo, a stage-matched chick embryo having one of these cell death is dramatically increased in the developing structures. In addition, cells engineered to produce Sonic nervous system and other tissues when the midline cells, hedgehog protein (SHH) can mimic the effect of the notochord and floor plate, are prevented from forming by notochord and floor plate cells in in situ grafts and excision of the axial-paraxial hinge (APH), i.e. caudal transplantation experiments. SHH can thus counteract a Hensen’s node and rostral primitive streak, at the 6-somite built-in cell death program and thereby contribute to organ stage (Charrier, J. B., Teillet, M.-A., Lapointe, F. and Le morphogenesis, in particular in the central nervous system. Douarin, N. M. (1999). Development 126, 4771-4783). In this paper we demonstrate that one day after APH excision, Key words: Apoptosis, Avian embryo, Cell death, Cell survival, when dramatic apoptosis is already present in the neural Floor plate, Notochord, Quail/chick, Shh, Somite, Neural tube, tube, the latter can be rescued from death by grafting a Spinal cord INTRODUCTION generally induces an inflammatory response.
    [Show full text]
  • Mechanisms of Programmed Cell Death in the Developing Brain
    _TINS July 2000 [final corr.] 12/6/00 10:39 am Page 291 R EVIEW Mechanisms of programmed cell death in the developing brain Chia-Yi Kuan, Kevin A. Roth, Richard A. Flavell and Pasko Rakic Programmed cell death (apoptosis) is an important mechanism that determines the size and shape of the vertebrate nervous system. Recent gene-targeting studies have indicated that homologs of the cell-death pathway in the nematode Caenorhabditis elegans have analogous functions in apoptosis in the developing mammalian brain.However,epistatic genetic analysis has revealed that the apoptosis of progenitor cells during early embryonic development and apoptosis of postmitotic neurons at later stage of brain development have distinct roles and mechanisms.These results provide new insight on the significance and mechanism of neural cell death in mammalian brain development. Trends Neurosci. (2000) 23, 291–297 ELL DEATH has long been recognized to occur in homologs of ced-3 comprise a family of cysteine- Cmost neuronal populations during normal devel- containing, aspartate-specific proteases called caspases5. opment of the vertebrate nervous system (reviewed in The ced-4 homolog is identified as one of the apoptosis Ref. 1). Traditionally, the investigation of neural death protease-activating factors (APAFs)6. The mammalian in development focused on the role of target-derived homologs of ced-9 belong to a growing family of Bcl2 survival factors such as NGF and related neurotrophins proteins, which share the Bcl2-homology (BH) domain (see Ref. 2 for a review). However, in the past few years, and are either pro- or anti-apoptotic7. The cloning of the genetic analysis of programmed cell death in the egl-1 indicates that it is similar to the BH3-domain- nematode Caenorhabditis elegans has inspired new ap- containing, pro-apoptotic subfamily of Bcl2 proteins4.
    [Show full text]
  • Correction1 4784..4785
    Correction Correction: PCI-24781 Induces Caspase and Reactive Oxygen Species-Dependent Apoptosis In the article on PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis published in the May 15, 2009 issue of Clinical Cancer Research, there was an error in Table 1. Down-regulated genes were incorrectly labeled as up-regulated genes. The correct table appears here. Bhalla S, Balasubramanian S, David K, et al. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-nB mechanisms and is synergistic with bortezomib in lymphoma cells. Clin Cancer Res 2009;15:3354–65. Table 1. Selected genes from expression analysis following 24-h treatment with PCI-24781, bortezomib, or the combination (in Ramos cells) Accn # Down-regulated genes 0.25 Mmol/L PCI/3 nmol/L Bor Name PCI-24781 Bortezomib Combination* Cell cycle-related NM_000075 Cyclin-dependent kinase 4 (CDK4) 0.49 0.83 0.37 NM_001237 Cyclin A2 (CCNA2) 0.43 0.87 0.37 NM_001950 E2F transcription factor 4, p107/p130-binding (E2F4) 0.48 0.79 0.40 NM_001951 E2F transcription factor 5, p130-binding (E2F5) 0.46 0.98 0.43 NM_003903 CDC16 cell division cycle 16 homolog (S cerevisiae) (CDC16) 0.61 0.78 0.43 NM_031966 Cyclin B1 (CCNB1) 0.55 0.90 0.43 NM_001760 Cyclin D3 (CCND3) 0.48 1.02 0.46 NM_001255 CDC20 cell division cycle 20 homolog (S cerevisiae; CDC20) 0.61 0.82 0.46 NM_001262 Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4; CDKN2C) 0.61 1.15 0.56 NM_001238 Cyclin E1 (CCNE1) 0.56 1.05 0.60 NM_001239 Cyclin H (CCNH) 0.74 0.90 0.64 NM_004701
    [Show full text]